Rare Diseases in South Africa: Bridging the Gap for Inclusive Healthcare
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
The Self-Medication Manufacturers’ Association of South Africa (SMASA) was formally formed in mid-1999 to ensure this important sector of the healthcare industry has a voice in discussions, which affect the health market place in South Africa.
SMASA consists of various member companies in the pharmaceutical and broader healthcare industry. The member companies elect representatives to an Executive Committee (EXCO), which meets regularly to discuss and take action on matters relevant to the industry. Kym Hampton is the current Chairperson of SMASA and Nicola Brink is the Executive Director of the Association.
The objectives of the Association are inter-alia to play a role in the promotion and support of legislative matters; to interact with government, other industry associations and statutory councils.
The Association promotes and protects the interests of the Members of the Association, encouraging co-operation between members and dealing with matters that may affect the common interests of members.
SMASA confers with the Government, and its departments, as well as other interested bodies and parties; and collects and disseminates information likely to be of use to members. Over the years SMASA has been involved in commenting on the Medicines Bill, the draft Benchmarking Regulations, the proposed Logistic Fees and Complementary Medicines and Medical Devices Regulations, Food Regulations, the scheduling of medicines and various guidelines for the registration of medicines, etc. In addition various meetings have been held with the Regulatory Authority on the ban of Advertising of Schedule 2 medicines, which remains an ongoing project. We are currently working with the WSMI (World Self-medication Industry) Task Group looking at the restrictions on the advertising of OTC medicines globally. SMASA continue to serve on various industry initiatives and hold two seats on the Industry Task Group (ITG). Other matters close to our heart are the Schedule 0 Exemption and the Consumer Protection Act.
SMASA has embarked on a PR campaign to promote responsible self-care and self-medication. This project each year culminates into International Self-care Day 24/7 on 24 July every year. SMASA is very active in other industry initiatives an example of which is the Codeine Care project which is a project introduced to mitigate the abuse and misuse of codiene and to accurately screen and control the sale of codeine containing OTC products in South Africa at a pharmacy level.
The Association has a Technical Committee looking at technical matters, including guidelines and policy matters from the Medicines Control Council and legislation.
SMASA is a member of the Marketing Code Authority and serves on the technical committee known as CTAC. SMASA has a seat on the board of the Marketing Code Association. In addition to the Association’s involvement in the compilation of Part A of the Code and the proposed Guideline for the Authority, we compiled Part B of the Code with the relevant Guidance Document for the Self-Medication Industry. In addition Nicola Brink serves as panelists to the Marketing Code on SMASA’s behalf.
SMASA is a member of the World Self-Medication Industry (WSMI) and benefits greatly from their activities. WSMI focuses on three core activities – support to emerging markets, and development of the ‘evidence base’ for non-prescription medicines, and collaborating with multi-lateral organizations.
Manufacturers and other organizations engaged in the self-medication manufacturing industry within South Africa are eligible for membership of the Association. Current members include:
Provision is made for a category called Associate Members who can be a person or a company involved in the supply chain between the manufacturer and the consumer or end-user of self-medication or industry consultants.
Associate members include:
Contact
Self-Medication Manufacturers Association of South Africa
Postal Address: P O Box 651573, Benmore, 2010
Tel: +27(0) 82 410 5859
Email: nicola@smasa.cc
Website: www.smasa.cc
Executive Director: Nicola Brink • Chairperson: Kym Hampton
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device industry has long enjoyed minimal barriers to entry and easy market access. But, with imminent…
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it comes to effectively treating more private and deeply personal health conditions, especially in…
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease profiles—these seem to be the fundamentals truly driving growth in South Africa’s clinical trial industry. However,…
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem for innovation, particularly in the world of biotechnology remains fruitful. Bioentrepreneur Nick Duneas…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract Manufacturing Companies (CMOs) within the South African Market. The managing director discusses the development…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit organizations funded by Baroque Medical, are well positioned to address South Africa’s current gaps…
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa and Sub-Saharan Africa, while also depicting how Bard has adapted its therapeutic portfolio…
The head of KPMG’s life science division in Africa, Joubert Krugel, discusses the current state of South Africa’s healthcare system, the imminent trends taking place, and how the business community…
Marius Fourie highlights implications of the recent merger between the company’s two subsidiaries and the unparalleled levels of value and service the consolidated organization will offer. He also illustrates the affiliate’s strategies…
Tania Zulu Holt, Associate Principal at McKinsey & Company elaborates on the current pressures on the South African healthcare system, discusses the importance of innovation and emphasizes the need for…
Abbvie GM for South Africa Christo Kruger highlights the various types of projects that the Public Health Enhancement Fund (PHEF) is pursuing to help alleviate the country’s currently overburdened healthcare…
See our Cookie Privacy Policy Here
